We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Synthomer Plc | SYNT | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 1.60 | 0.96% | 168.60 | 16:35:10 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 166.00 | 166.00 | 171.00 | 168.60 | 167.00 |
| Industry Sector |
|---|
| CHEMICALS |
| Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
| 03/03/2022 | Final | GBP | 0.213 | 01/06/2022 | 06/06/2022 | 05/07/2022 |
| 05/08/2021 | Interim | GBP | 0.087 | 07/10/2021 | 08/10/2021 | 04/11/2021 |
| 04/03/2021 | Final | GBP | 0.086 | 03/06/2021 | 04/06/2021 | 05/07/2021 |
| 14/10/2020 | Interim | GBP | 0.03 | 22/10/2020 | 23/10/2020 | 10/11/2020 |
| Top Posts |
|---|
Posted at 14/8/2024 16:11 by napoleon 14th Stockopedia on SYNT, 130824Paul’s opinion - I think this is still quite a big mess. Bulls must be hoping to see a dramatic improvement in future profitability, which is needed to reduce debt down to more normal levels. To me, risk:reward seems poor right now, with a mountain of debt to service, let alone repay. Cashflow looks very poor in H1, and wasn’t great last year either, with the only significant cash inflows coming from disposals, and the £266m equity fundraise last year. I reckon that probably won’t be the last equity raise. Remember I’m only analysing the basic numbers, not trying to predict how the business will perform in future. If you think there’s a spectacular turnaround opportunity here, then it might be worth taking on all the risk. Each 1% rise in profit margin is £20m extra profit - not bad if they can raise margins in an economic recovery. For me, it has to be AMBER/RED again, to flag that this is still an overly-indebted business, and it’s not trading very well either, with no particular upside yet apparent in the outlook comments either. Shareholders have to hope that changes for the better. Maybe I've missed something, as the StockRanks are mildly positive on this share - |
Posted at 28/5/2024 08:09 by institutional investments SYNT is fine. hit an old event price and came back to buyers that will double down. next time to assess is in the 500s |
Posted at 27/5/2024 10:01 by eigthwonder One of the key issues is the nitrile (glove) business. Pre-Covid it was a steady growth market where supply was pretty well matched to demand by the the key players (including SYNT). Obviously Covid caused a massive spike in demand which was very useful but it also attracted more supply than needed in ordinary times. So we really need demand and supply to be back in equilibrium to kick on. |
Posted at 24/5/2024 11:40 by eigthwonder In the UK market the ELM story is further advanced and therefore more certain IMO, but if by "best" you mean the one with the highest prospective returns for equity holders my money would be (and is) on SYNT. The other candidate, where I am less well informed, is JMAT. |
Posted at 24/5/2024 10:03 by hopan Do you think SYNT is the best best for chemicals recovery? |
Posted at 08/5/2024 16:36 by eigthwonder Knowing a little how these things work….Numis are broker to fellow speciality chemicals outfit Elementis but not Synthomer; I doubt the analyst will ever be more positive on SYNT than ELM. |
Posted at 22/2/2024 14:43 by libertine 22 February 2024Synthomer still a ‘buy’ for Peel Hunt but disposals are needed Disposals are needed at Synthomer (SYNT) to catalyse a rerating of the chemical company’s shares, says Peel Hunt. Analyst Harry Philips retained his ‘buy’ recommendation but reduced the target price from 320p to 250p on the Citywire Elite Companies A-rated stock, which shed 2.4%, or 3.7p, to 151p on Wednesday. The shares are down 86% over the past year after swinging to a loss-making position and being forced to go cap in hand to the market in a £276m raise. Philips said ‘disposals are needed to accelerate the deleveraging process’. ‘In our view, the company has raised just enough, but without disposals, a rerating to our 250p target price is unlikely to happen organically in the short to medium term,’ he said. ‘We see the stock as an eyes-open “buy” that still has bumps and challenges, but also has a platform.’ |
Posted at 07/2/2024 10:59 by libertine EXPERT VIEW06 FEB, 2024 Berenberg recommends ‘buy’ Synthomer Specialist chemicals group Synthomer (SYNT) is at ‘the right time in the cycle for some action’, according to Berenberg. Analyst Sebastian Bray retained his ‘buy’ recommendation and target price of 320p on the Citywire Elite Companies A-rated stock, which fell 5.1% to 143.1p on Monday. Bray said the ‘key message’ from the trading update this month was that debt is down, with the corollary being that the shares increased ‘despite continued headwinds to the adhesives unit’ that saw earnings decrease modestly below consensus expectations. ‘Rising China chemicals imports and a recent bottoming of base chemicals prices in our view signal the start of a recovery in demand for chemicals in 2024,’ said Bray. ‘The pick-up in Synthomer’s volumes of nitrile latex in the fourth quarter appears consistent with the beginnings of a modest recovery, as reflected in the 12% rally in TopGlove shares since the start of December.’ He added that Synthomer is one of the ‘most levered to a macro recovery in European chemicals’. |
Posted at 11/1/2024 13:36 by darrin1471 LOTM "They allowed the £1B purchase to go ahead without proper financing to be in place at the time. A criminal decision."At the time of the acquisition (28/10/2021) BofE rates were 0.1%, we were exiting covid and the SYNT share price was near all time highs. Congratulations to all of those who had a crystal ball in 2021 and shorted SYNT. The share price was not a sudden collapse but a long 2 year fall. There was plenty of opportunity to sell. Small investors either took their eye off the ball or stuck their heads in the sand. I don't have a crystal ball but today the SYNT mkt cap looks good value, higher than average risk with higher than average potential reward. I still hold no position long or short in SYNT. |
Posted at 27/11/2023 22:40 by darrin1471 wigwammer. Thanks for the heads up on McBride 18 months ago. Last months rise makes it my biggest holding. I continue to hold MCB as I see further upside in re-valuation and even higher profits.I've had SYNT on a watch list for a few months and now the dust has settled I have taken a deeper look and I quite like the look of what I see. The strategy of a specialist chemicals company looks sound. The price SYNT paid for Omnova and Eastman’s Adhesive Resins looks reasonable. The Eastman’s timing is unfortunate but at the time of the acquisition (28/10/2021) BofE rates were 0.1%, we were exiting covid and the SYNT share price was near all time highs. The sale of non core business and the return of normal trading conditions should lead to a significant recovery. I hold no position in SYNT at the moment. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
